United Drug: Euro to stay reporting currency

United Drug has announced it intends to keep the euro as its reporting currency, despite its shares now being listed in London.

The Dublin-headquartered healthcare services group switched from the Iseq to the London Stock Exchange last October. With almost three-quarters of the group’s annual earnings now generated outside of Ireland, management viewed the move as a “natural progression” and one which would help the business attract a wider international investor audience.

In its latest trading update, issued yesterday, United’s management said it had conducted a review to consider if the group’s results should be reported in sterling or euro.